Viatris To Acquire Pacira BioSciences - What Investors Should Know (NASDAQ:VTRS)

seekingalpha.com · 2026-10-09

Viatris is acquiring Pacira Biosciences to boost its pain management portfolio and address revenue stagnation. Read why VTRS stock is upgraded to a hold.

Read the full story at seekingalpha.com →